Law360, New York (June 15, 2012, 2:36 PM EDT) -- Janssen Products LP, a subsidiary of Johnson & Johnson, sued a trio of pharmaceutical companies in New Jersey federal court Wednesday, accusing them of infringing Janssen's patented Prezista and seeking an injunction to stop them from pursuing generic versions of the HIV drug.
Janssen’s complaints allege that attempts by Mylan Pharmaceuticals Inc., Hetero Drugs Ltd., and Teva Pharmaceuticals USA Inc. to produce generic versions of the successful drug violated three patents.
Hetero informed Janssen in February 2011 that it had filed an abbreviated new drug application...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.